JPH11507627A5 - - Google Patents

Info

Publication number: JPH11507627A5
Authority: JP; Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

JP1997501678A

Other languages

English (en)

Japanese (ja)

Other versions

JPH11507627A (ja

Filing date

1996-06-05

Publication date

2004-07-22

1996-06-05 Application filed filed Critical

1996-06-05 Priority claimed from PCT/US1996/009335 external-priority patent/WO1996040257A1/en

1999-07-06 Publication of JPH11507627A publication Critical patent/JPH11507627A/ja

2004-07-22 Publication of JPH11507627A5 publication Critical patent/JPH11507627A5/ja

Status Ceased legal-status Critical Current

Links

JP9501678A 1995-06-07 1996-06-05 充血性心不全症を処置するためのエポキシ−ステロイド系アルドステロン拮抗物質とアンギオテンシンｉｉ拮抗物質との組合せ治療 Ceased JPH11507627A (ja)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US48645695A	1995-06-07	1995-06-07
US08/486,456		1995-06-07
PCT/US1996/009335 WO1996040257A1 (en)	1995-06-07	1996-06-05	Epoxy-steroidal aldosterone antagonist and angiotensin ii antagonist combination therapy for treatment of congestive heart failure

Publications (2)

Publication Number	Publication Date
JPH11507627A JPH11507627A (ja)	1999-07-06
JPH11507627A5 true JPH11507627A5 (2)	2004-07-22

Family

ID=23931955

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP9501678A Ceased JPH11507627A (ja)	1995-06-07	1996-06-05	充血性心不全症を処置するためのエポキシ−ステロイド系アルドステロン拮抗物質とアンギオテンシンｉｉ拮抗物質との組合せ治療

Country Status (21)

Country	Link
US (1)	US6653306B1 (2)
EP (1)	EP0831910B1 (2)
JP (1)	JPH11507627A (2)
KR (1)	KR100618466B1 (2)
CN (2)	CN1522701A (2)
AT (1)	ATE209047T1 (2)
AU (1)	AU725689B2 (2)
BR (1)	BR9609066A (2)
CA (1)	CA2224079A1 (2)
CZ (1)	CZ297975B6 (2)
DE (1)	DE69617235T2 (2)
DK (1)	DK0831910T3 (2)
ES (1)	ES2167571T3 (2)
IL (1)	IL122242A (2)
NO (1)	NO318184B1 (2)
NZ (1)	NZ310730A (2)
PL (1)	PL185150B1 (2)
PT (1)	PT831910E (2)
RO (1)	RO118046B1 (2)
RU (1)	RU2166330C2 (2)
WO (1)	WO1996040257A1 (2)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1249682A (zh) *	1997-01-10	2000-04-05	麦克公司	用于治疗有症状的心力哀竭的血管紧张素ⅱ拮抗剂
US6201002B1 (en)	1997-01-10	2001-03-13	Merck & Co., Inc.	Method for reducing mortality with an angiotensin II antagonist
US6306826B1 (en)	1997-06-04	2001-10-23	The Regents Of The University Of California	Treatment of heart failure with growth hormone
HK1042252B (en) *	1999-03-05	2004-04-23	G.D. Searle Llc	Combination therapy of angiotensin converting enzyme inhibitor and epoxy-steroidal aldosterone antagonist for treatment of cardiovascular disease
US6211217B1 (en)	1999-03-16	2001-04-03	Novartis Ag	Method for reducing pericardial fibrosis and adhesion formation
US20030083342A1 (en) *	2002-08-27	2003-05-01	Steele Ronald Edward	Combination of organic compounds
EP1280533A2 (en) *	2000-05-11	2003-02-05	Pharmacia Corporation	Aldosterone antagonist composition for release during aldosterone acrophase
CZ20024180A3 (cs) *	2000-06-22	2003-04-16	Novartis Ag	Pevné orální farmaceutické kompozice obsahující valsartan
WO2002009761A2 (en) *	2000-07-27	2002-02-07	Pharmacia Corporation	Epoxy-steroidal aldosterone antagonist and calcium channel blocker combination therapy for treatment of congestive heart failure
ES2269442T3 (es) *	2000-07-27	2007-04-01	Pharmacia Corporation	Terapia de combinacion de antagonista de aldosterona e inhibidor de ciclooxigenasa-2 para prevenir o tratar trastornos cardiovasculares relacionados con la inflamacion.
AU2002351412B2 (en)	2001-12-21	2010-05-20	Exelixis Patent Company Llc	Modulators of LXR
US7482366B2 (en)	2001-12-21	2009-01-27	X-Ceptor Therapeutics, Inc.	Modulators of LXR
US20050124624A1 (en) *	2002-03-15	2005-06-09	Gilbert Richard E.	4-(4-methylpiperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-yl-amino)phenyl]-benzamide for threating ang ii-mediated diseases
GB0212412D0 (en) *	2002-05-29	2002-07-10	Novartis Ag	Combination of organic compounds
CL2004000545A1 (es) *	2003-03-18	2005-01-28	Pharmacia Corp Sa Organizada B	Uso de un antagonista de los receptores de aldosterona y un antagonista de receptores de endotelina para el tratamiento o profilaxis de una condicion patologica relacionada con hipertension, disfuncion renal, insulinopatia y enfermedades cardiovascul
US20050153885A1 (en) *	2003-10-08	2005-07-14	Yun Anthony J.	Treatment of conditions through modulation of the autonomic nervous system
WO2005039637A2 (en) *	2003-10-17	2005-05-06	Novartis Ag	Combinations of an aldosterone receptor antagonist, a diuretic and an angiotensin blocker
CA2568640C (en)	2004-06-04	2011-08-09	Teva Pharmaceutical Industries Ltd.	Pharmaceutical composition containing irbesartan
US8569277B2 (en)	2004-08-11	2013-10-29	Palo Alto Investors	Methods of treating a subject for a condition
EP1831225A2 (en)	2004-11-19	2007-09-12	The Regents of the University of California	Anti-inflammatory pyrazolopyrimidines
CN101024643A (zh) *	2006-02-20	2007-08-29	上海艾力斯医药科技有限公司	咪唑－5－羧酸类衍生物、制备方法及其应用
EA200870409A1 (ru)	2006-04-04	2009-04-28	Дзе Риджентс Оф Дзе Юниверсити Оф Калифорния	Антагонисты киназы pi3
GB2467670B (en)	2007-10-04	2012-08-01	Intellikine Inc	Chemical entities and therapeutic uses thereof
CA2711558C (en) *	2008-01-04	2016-12-13	Intellikine, Inc.	Phosphatidyl inositol-3 kinase inhibiting compounds
US8193182B2 (en)	2008-01-04	2012-06-05	Intellikine, Inc.	Substituted isoquinolin-1(2H)-ones, and methods of use thereof
JP5547099B2 (ja)	2008-03-14	2014-07-09	インテリカイン，エルエルシー	キナーゼ阻害剤および使用方法
US8993580B2 (en)	2008-03-14	2015-03-31	Intellikine Llc	Benzothiazole kinase inhibitors and methods of use
AU2009268611B2 (en)	2008-07-08	2015-04-09	Intellikine, Llc	Kinase inhibitors and methods of use
WO2010006072A2 (en)	2008-07-08	2010-01-14	The Regents Of The University Of California	Mtor modulators and uses thereof
JP5731978B2 (ja)	2008-09-26	2015-06-10	インテリカイン，エルエルシー	複素環キナーゼ阻害剤
CA2740885C (en)	2008-10-16	2018-04-03	The Regents Of The University Of California	Fused ring heteroaryl kinase inhibitors
US8476282B2 (en)	2008-11-03	2013-07-02	Intellikine Llc	Benzoxazole kinase inhibitors and methods of use
PE20120593A1 (es)	2009-01-30	2012-05-21	Takeda Pharmaceutical	Derivados fusionados de pirimidin-4-ona como antagonistas del receptor de angiotensina ii y como agonistas del receptor ppar gamma
EP2427195B1 (en)	2009-05-07	2019-05-01	Intellikine, LLC	Heterocyclic compounds and uses thereof
WO2011047384A2 (en)	2009-10-16	2011-04-21	The Regents Of The University Of California	Methods of inhibiting ire1
AU2011255218B2 (en)	2010-05-21	2015-03-12	Infinity Pharmaceuticals, Inc.	Chemical compounds, compositions and methods for kinase modulation
JP2013545749A (ja)	2010-11-10	2013-12-26	インフィニティーファーマシューティカルズ，インコーポレイテッド	複素環化合物及びその使用
AU2012205669B2 (en)	2011-01-10	2015-08-20	Infinity Pharmaceuticals Inc.	Processes for preparing isoquinolinones and solid forms of isoquinolinones
JP6130305B2 (ja)	2011-02-23	2017-05-17	インテリカイン，エルエルシー	キナーゼ阻害剤の組み合わせおよびそれらの使用
JP6027610B2 (ja)	2011-07-19	2016-11-16	インフィニティーファーマシューティカルズ，インコーポレイテッド	複素環式化合物及びその使用
US9056877B2 (en)	2011-07-19	2015-06-16	Infinity Pharmaceuticals, Inc.	Heterocyclic compounds and uses thereof
EP2751093A1 (en)	2011-08-29	2014-07-09	Infinity Pharmaceuticals, Inc.	Heterocyclic compounds and uses thereof
MX370814B (es)	2011-09-02	2020-01-08	Univ California	Pirazolo[3,4-d]pirimidinas sustituidas y usos de las mismas.
US8809372B2 (en)	2011-09-30	2014-08-19	Asana Biosciences, Llc	Pyridine derivatives
US9199975B2 (en)	2011-09-30	2015-12-01	Asana Biosciences, Llc	Biaryl imidazole derivatives for regulating CYP17
US8940742B2 (en)	2012-04-10	2015-01-27	Infinity Pharmaceuticals, Inc.	Heterocyclic compounds and uses thereof
US8828998B2 (en)	2012-06-25	2014-09-09	Infinity Pharmaceuticals, Inc.	Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors
MX2015003874A (es)	2012-09-26	2015-12-16	Univ California	Modulacion de ire1.
KR102229478B1 (ko)	2012-11-01	2021-03-18	인피니티 파마슈티칼스, 인코포레이티드	Pi3 키나아제 동형단백질 조절인자를 사용하는 암의 치료
US9481667B2 (en)	2013-03-15	2016-11-01	Infinity Pharmaceuticals, Inc.	Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
US9751888B2 (en)	2013-10-04	2017-09-05	Infinity Pharmaceuticals, Inc.	Heterocyclic compounds and uses thereof
PE20160685A1 (es)	2013-10-04	2016-07-23	Infinity Pharmaceuticals Inc	Compuestos heterociclicos y usos de los mismos
SG10201808053XA (en)	2014-03-19	2018-10-30	Infinity Pharmaceuticals Inc	Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders
US20150320755A1 (en)	2014-04-16	2015-11-12	Infinity Pharmaceuticals, Inc.	Combination therapies
US9708348B2 (en)	2014-10-03	2017-07-18	Infinity Pharmaceuticals, Inc.	Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof
US10160761B2 (en)	2015-09-14	2018-12-25	Infinity Pharmaceuticals, Inc.	Solid forms of isoquinolinones, and process of making, composition comprising, and methods of using the same
WO2017161116A1 (en)	2016-03-17	2017-09-21	Infinity Pharmaceuticals, Inc.	Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors
US10919914B2 (en)	2016-06-08	2021-02-16	Infinity Pharmaceuticals, Inc.	Heterocyclic compounds and uses thereof
MX391135B (es)	2016-06-24	2025-03-21	Infinity Pharmaceuticals Inc	Terapias de combinacion.
WO2018005591A1 (en)	2016-06-29	2018-01-04	Universite De Montreal	Biarylmethyl heterocycles
WO2018002673A1 (en)	2016-07-01	2018-01-04	N4 Pharma Uk Limited	Novel formulations of angiotensin ii receptor antagonists
DK3873904T3 (da)	2018-10-29	2024-08-05	Myokardia Inc	Tetrahydropyran (THP)-substitueret bicycklisk pyrimidindionforbindelser
EP3886854A4 (en)	2018-11-30	2022-07-06	Nuvation Bio Inc.	Pyrrole and pyrazole compounds and methods of use thereof
US11971205B2 (en)	2021-08-20	2024-04-30	Pioneer Family Brands, Inc.	Ice shaver with splash guard
US11982483B2 (en)	2021-08-20	2024-05-14	Pioneer Family Brands, Inc.	Ice shaver with multi-link control arm
US12044455B2 (en)	2021-08-20	2024-07-23	Pioneer Family Brands, Inc.	Ice shaver with thermally isolated shave deck

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4559332A (en) *	1983-04-13	1985-12-17	Ciba Geigy Corporation	20-Spiroxanes and analogues having an open ring E, processes for their manufacture, and pharmaceutical preparations thereof
US4880804A (en) *	1988-01-07	1989-11-14	E. I. Du Pont De Nemours And Company	Angiotensin II receptor blocking benzimidazoles
CA2053148A1 (en) *	1990-10-16	1992-04-17	Karnail Atwal	Dihydropyrimidine derivatives
US5049565A (en) *	1990-12-07	1991-09-17	Merck & Co., Inc.	Microbial transformation process for preparing anti-hypertensive products
CA2109524A1 (en) *	1991-05-10	1992-11-11	Prasun K. Chakravarty	Acidic aralkyl triazole derivatives active as angiotensin ii antagonists
US5529992A (en) *	1992-04-21	1996-06-25	Curators Of The University Of Missouri	Method for inhibiting myocardial fibrosis by administering an aldosterone antagonist which suppresses aldoster one receptors
US6008210A (en) *	1992-04-21	1999-12-28	Weber; Karl T.	Use of aldosterone antagonists to inhibit myocardial fibrosis
AU5449194A (en) *	1992-10-26	1994-05-24	Merck & Co., Inc.	Combinations of angiotensin-ii receptor antagonists and diuretics
CA2125251C (en) *	1993-06-07	2005-04-26	Yoshiyuki Inada	A pharmaceutical composition for angiotensin ii-mediated diseases

1996
- 1996-06-05 ES ES96919170T patent/ES2167571T3/es not_active Expired - Lifetime
- 1996-06-05 AU AU61577/96A patent/AU725689B2/en not_active Ceased
- 1996-06-05 CA CA002224079A patent/CA2224079A1/en not_active Abandoned
- 1996-06-05 JP JP9501678A patent/JPH11507627A/ja not_active Ceased
- 1996-06-05 AT AT96919170T patent/ATE209047T1/de not_active IP Right Cessation
- 1996-06-05 PT PT96919170T patent/PT831910E/pt unknown
- 1996-06-05 RO RO97-02272A patent/RO118046B1/ro unknown
- 1996-06-05 CZ CZ0385097A patent/CZ297975B6/cs not_active IP Right Cessation
- 1996-06-05 KR KR1019970709029A patent/KR100618466B1/ko not_active Expired - Fee Related
- 1996-06-05 CN CNA2004100027960A patent/CN1522701A/zh active Pending
- 1996-06-05 DK DK96919170T patent/DK0831910T3/da active
- 1996-06-05 DE DE69617235T patent/DE69617235T2/de not_active Expired - Fee Related
- 1996-06-05 EP EP96919170A patent/EP0831910B1/en not_active Expired - Lifetime
- 1996-06-05 NZ NZ310730A patent/NZ310730A/xx unknown
- 1996-06-05 BR BR9609066A patent/BR9609066A/pt not_active Application Discontinuation
- 1996-06-05 PL PL96324001A patent/PL185150B1/pl not_active IP Right Cessation
- 1996-06-05 IL IL12224296A patent/IL122242A/en not_active IP Right Cessation
- 1996-06-05 RU RU98100250/14A patent/RU2166330C2/ru not_active IP Right Cessation
- 1996-06-05 CN CNB961961554A patent/CN1142793C/zh not_active Expired - Fee Related
- 1996-06-05 WO PCT/US1996/009335 patent/WO1996040257A1/en not_active Ceased
1997
- 1997-01-09 US US08/781,786 patent/US6653306B1/en not_active Expired - Fee Related
2004
- 2004-11-23 NO NO19975741A patent/NO318184B1/no unknown

Publication	Publication Date	Title
JP2000500033A5 (2)	2004-09-09
JP2000500228A5 (2)	2004-09-09
JP2000500440A5 (2)	2004-10-21
JP2000500327A5 (2)	2005-10-06
JP2000501440A5 (2)	2004-10-21
JP2000500145A5 (2)	2004-10-14
JP2000500155A5 (2)	2004-10-21
JP2001527509A5 (2)	2004-07-29
JP2000500361A5 (2)	2004-10-14
JPH11512762A5 (2)	2004-09-16
JP2000500115A5 (2)	2004-07-08
JP2000500258A5 (2)	2004-08-12
JP2000500342A5 (2)	2004-10-21
JP2000500192A5 (2)	2004-07-15
JP2000500112A5 (2)	2004-10-14
JP2000502320A5 (2)	2004-08-19
JP2000500051A5 (2)	2004-10-14
JP2000500397A5 (2)	2004-10-21
JP2000500166A5 (2)	2004-09-24
JP2000500019A5 (2)	2004-11-04
JP2000500125A5 (2)	2004-10-21
JP2000500044A5 (2)	2006-01-05
JP2000500346A5 (2)	2005-06-16
JP2000500090A5 (2)	2005-11-24
JP2000500257A5 (2)	2004-08-12